nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.423	0.577	CbGbCtD
Bevantolol—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.311	0.423	CbGbCtD
Bevantolol—Carvedilol—NPPB—type 2 diabetes mellitus	0.00302	0.147	CrCbGaD
Bevantolol—Carvedilol—GJA1—type 2 diabetes mellitus	0.00302	0.147	CrCbGaD
Bevantolol—Carvedilol—HIF1A—type 2 diabetes mellitus	0.00229	0.111	CrCbGaD
Bevantolol—Verapamil—KCNJ11—type 2 diabetes mellitus	0.00137	0.0666	CrCbGaD
Bevantolol—Carvedilol—ADRB3—type 2 diabetes mellitus	0.00136	0.0663	CrCbGaD
Bevantolol—Tamsulosin—ADRA2A—type 2 diabetes mellitus	0.0012	0.0586	CrCbGaD
Bevantolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.00104	0.0504	CrCbGaD
Bevantolol—Carvedilol—VEGFA—type 2 diabetes mellitus	0.000921	0.0448	CrCbGaD
Bevantolol—Verapamil—ABCC2—type 2 diabetes mellitus	0.00074	0.036	CrCbGaD
Bevantolol—Carvedilol—ADRA2A—type 2 diabetes mellitus	0.000617	0.03	CrCbGaD
Bevantolol—Ranolazine—CYP3A4—type 2 diabetes mellitus	0.000575	0.028	CrCbGaD
Bevantolol—Tamsulosin—CYP3A4—type 2 diabetes mellitus	0.000554	0.0269	CrCbGaD
Bevantolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.000535	0.026	CrCbGaD
Bevantolol—Verapamil—CYP1A2—type 2 diabetes mellitus	0.000494	0.024	CrCbGaD
Bevantolol—Propafenone—CYP1A2—type 2 diabetes mellitus	0.000476	0.0232	CrCbGaD
Bevantolol—Carvedilol—CYP2E1—type 2 diabetes mellitus	0.000451	0.0219	CrCbGaD
Bevantolol—Carvedilol—CYP1A2—type 2 diabetes mellitus	0.000429	0.0209	CrCbGaD
Bevantolol—Verapamil—CYP3A4—type 2 diabetes mellitus	0.000327	0.0159	CrCbGaD
Bevantolol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000326	0.0159	CrCbGaD
Bevantolol—Propafenone—CYP3A4—type 2 diabetes mellitus	0.000315	0.0153	CrCbGaD
Bevantolol—Carvedilol—CYP3A4—type 2 diabetes mellitus	0.000284	0.0138	CrCbGaD
Bevantolol—Propranolol—CYP3A4—type 2 diabetes mellitus	0.000216	0.0105	CrCbGaD
Bevantolol—ADRA1A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	7.27e-05	0.000296	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	7.22e-05	0.000294	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	7.21e-05	0.000294	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	7.15e-05	0.000291	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	7.14e-05	0.00029	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	7.12e-05	0.00029	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	7.09e-05	0.000289	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	7.06e-05	0.000287	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	7.05e-05	0.000287	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.98e-05	0.000284	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.94e-05	0.000283	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.94e-05	0.000282	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.92e-05	0.000282	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.92e-05	0.000281	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	6.9e-05	0.000281	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.88e-05	0.00028	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.79e-05	0.000276	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.79e-05	0.000276	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.77e-05	0.000276	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	6.77e-05	0.000275	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.77e-05	0.000275	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.73e-05	0.000274	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	6.71e-05	0.000273	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	6.65e-05	0.00027	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	6.65e-05	0.00027	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.64e-05	0.00027	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	6.64e-05	0.00027	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.59e-05	0.000268	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	6.55e-05	0.000267	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	6.49e-05	0.000264	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.48e-05	0.000264	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.48e-05	0.000264	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.46e-05	0.000263	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.46e-05	0.000263	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.45e-05	0.000262	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	6.45e-05	0.000262	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.43e-05	0.000262	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.42e-05	0.000261	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.4e-05	0.00026	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.4e-05	0.00026	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.37e-05	0.000259	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	6.31e-05	0.000257	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.28e-05	0.000255	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.26e-05	0.000255	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.26e-05	0.000255	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.23e-05	0.000253	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.2e-05	0.000252	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.2e-05	0.000252	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	6.17e-05	0.000251	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.15e-05	0.00025	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.09e-05	0.000248	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.09e-05	0.000248	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.07e-05	0.000247	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.07e-05	0.000247	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.07e-05	0.000247	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.06e-05	0.000247	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.05e-05	0.000246	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.99e-05	0.000244	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.96e-05	0.000243	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.94e-05	0.000242	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.94e-05	0.000242	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.91e-05	0.000241	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.86e-05	0.000239	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.84e-05	0.000238	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.83e-05	0.000237	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.77e-05	0.000235	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.74e-05	0.000233	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—INSR—type 2 diabetes mellitus	5.7e-05	0.000232	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.7e-05	0.000232	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.64e-05	0.00023	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.62e-05	0.000229	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.62e-05	0.000229	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.6e-05	0.000228	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.6e-05	0.000228	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.57e-05	0.000227	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.55e-05	0.000226	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.55e-05	0.000226	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.52e-05	0.000225	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.5e-05	0.000224	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.5e-05	0.000224	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.46e-05	0.000222	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.44e-05	0.000221	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.43e-05	0.000221	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.43e-05	0.000221	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—C3—type 2 diabetes mellitus	5.37e-05	0.000219	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.34e-05	0.000217	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.33e-05	0.000217	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.32e-05	0.000217	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.19e-05	0.000211	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.19e-05	0.000211	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.18e-05	0.000211	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.18e-05	0.000211	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.1e-05	0.000208	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.1e-05	0.000208	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.1e-05	0.000207	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.08e-05	0.000207	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.04e-05	0.000205	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.02e-05	0.000204	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.02e-05	0.000204	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.99e-05	0.000203	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.99e-05	0.000203	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.93e-05	0.000201	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.91e-05	0.0002	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.91e-05	0.0002	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.85e-05	0.000197	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.83e-05	0.000196	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.78e-05	0.000195	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.72e-05	0.000192	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.72e-05	0.000192	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.72e-05	0.000192	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.71e-05	0.000192	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.7e-05	0.000191	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.68e-05	0.00019	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.68e-05	0.00019	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.63e-05	0.000188	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.62e-05	0.000188	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.62e-05	0.000188	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.6e-05	0.000187	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.58e-05	0.000186	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.57e-05	0.000186	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.56e-05	0.000186	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.55e-05	0.000185	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.54e-05	0.000185	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.53e-05	0.000184	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.49e-05	0.000183	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	4.49e-05	0.000183	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.49e-05	0.000183	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.46e-05	0.000182	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.44e-05	0.000181	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.42e-05	0.00018	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.4e-05	0.000179	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.39e-05	0.000179	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.35e-05	0.000177	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.26e-05	0.000173	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.26e-05	0.000173	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.2e-05	0.000171	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.17e-05	0.00017	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.13e-05	0.000168	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.12e-05	0.000168	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.09e-05	0.000166	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.01e-05	0.000163	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4e-05	0.000163	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.92e-05	0.00016	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	3.92e-05	0.00016	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.91e-05	0.000159	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.87e-05	0.000157	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	3.84e-05	0.000156	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	3.82e-05	0.000155	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.82e-05	0.000155	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.8e-05	0.000155	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.78e-05	0.000154	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.75e-05	0.000152	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.74e-05	0.000152	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.73e-05	0.000152	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.73e-05	0.000152	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	3.69e-05	0.00015	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.68e-05	0.00015	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.66e-05	0.000149	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.66e-05	0.000149	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.65e-05	0.000149	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.65e-05	0.000149	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.65e-05	0.000148	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.64e-05	0.000148	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.63e-05	0.000148	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.61e-05	0.000147	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.58e-05	0.000146	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.57e-05	0.000145	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.57e-05	0.000145	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.53e-05	0.000144	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	3.52e-05	0.000143	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.45e-05	0.00014	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.44e-05	0.00014	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.37e-05	0.000137	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.31e-05	0.000135	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.26e-05	0.000133	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.25e-05	0.000132	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.19e-05	0.00013	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	3.17e-05	0.000129	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	3.12e-05	0.000127	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.07e-05	0.000125	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	3.05e-05	0.000124	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.03e-05	0.000123	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.02e-05	0.000123	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.02e-05	0.000123	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.01e-05	0.000123	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.01e-05	0.000123	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3e-05	0.000122	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3e-05	0.000122	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.96e-05	0.000121	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.95e-05	0.00012	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.95e-05	0.00012	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.95e-05	0.00012	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.95e-05	0.00012	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.94e-05	0.000119	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.92e-05	0.000119	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.86e-05	0.000117	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.8e-05	0.000114	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.79e-05	0.000113	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.73e-05	0.000111	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.73e-05	0.000111	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.68e-05	0.000109	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.68e-05	0.000109	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.63e-05	0.000107	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.57e-05	0.000105	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.52e-05	0.000103	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.52e-05	0.000102	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.48e-05	0.000101	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.44e-05	9.93e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.44e-05	9.92e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.43e-05	9.88e-05	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.34e-05	9.54e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.32e-05	9.45e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.32e-05	9.43e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.31e-05	9.39e-05	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.29e-05	9.33e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.27e-05	9.24e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.26e-05	9.18e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.21e-05	9e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.21e-05	9e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.19e-05	8.93e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.17e-05	8.83e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.15e-05	8.73e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.13e-05	8.66e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.12e-05	8.64e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.08e-05	8.47e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.08e-05	8.47e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.02e-05	8.23e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.98e-05	8.05e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.97e-05	8.02e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.93e-05	7.84e-05	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.9e-05	7.72e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.88e-05	7.64e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.87e-05	7.59e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.81e-05	7.36e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.78e-05	7.22e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.77e-05	7.21e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.77e-05	7.2e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.76e-05	7.15e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.73e-05	7.06e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.72e-05	7.01e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.64e-05	6.66e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.59e-05	6.49e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.46e-05	5.95e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.43e-05	5.84e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.36e-05	5.54e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.33e-05	5.42e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.26e-05	5.12e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.23e-05	5e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.1e-05	4.49e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-05	4.14e-05	CbGpPWpGaD
